Navigation Links
Stem Cell Public Lecture by Dr. Tom Gionis and Dr. Nia Smyrniotis
Date:11/15/2013

Miami, Florida (PRWEB) November 15, 2013

The Miami Stem Cell Treatment Center, PC, announces a series of free public seminars on the use of stem cells for various degenerative and inflammatory conditions. They will be provided by Dr. Thomas A. Gionis, Surgeon-in-Chief, and, Dr. Nia Smyrniotis, Medical Director.

The seminars will be held on November 17 and 18. On November 17, the seminar will be held at the Marriott Boca Raton, at Boca Center, 5150 Town Center Circle, Boca Raton Florida 33486, at 12 and 4 p.m.; and on November 18 at the Courtyard Fort Lauderdale Beach Marriott, 440 Seabreeze Blvd., Fort Lauderdale Florida 33316, at 1 and 6 pm.

At the Miami Stem Cell Treatment Center, utilizing investigational protocols, adult adipose derived stem cells (ADSCs) can be deployed to improve patients’ quality of life for a number of degenerative conditions and diseases. ADSCs are taken from the patient’s own adipose (fat) tissue (also called stromal vascular fraction (SVF)). Adipose tissue is exceptionally abundant in ADSCs. The adipose tissue is obtained from the patient during a 15 minute mini- liposuction performed under local anesthesia in the doctor’s office. SVF is a protein-rich solution containing mononuclear cell lines (predominantly autologous mesenchymal stem cells), macrophage cells, endothelial cells, red blood cells, and important Growth Factors that facilitate the stem cell process and promote their activity.

ADSCs are the body's natural healing cells - they are recruited by chemical signals emitted by damaged tissues to repair and regenerate the body’s injured cells. The Miami Stem Cell Treatment Center only uses autologous stem cells from a person's own fat – no embryonic stem cells are used. Our current areas of study include: Heart Failure, Emphysema, COPD, Asthma, Parkinson’s Disease, Stroke, Multiple Sclerosis, and orthopedic joint injections. For more information, or if someone thinks they may be a candidate for one of the stem cell protocols offered by Miami Stem Cell Treatment Center, they may contact Dr. Nia or Dr. Gionis directly at (561) 331-2999, or see a complete list of the Center’s study areas at: http://www.MiamiStemCellsUSA.com.

About Miami Stem Cell Treatment Center:
The Miami Stem Cell Treatment Center is an affiliate of the Irvine Stem Cell Treatment Center (Irvine, California) and the Cell Surgical Network (CSN); they are located in Miami, Ft. Lauderdale, and Boca Raton, Florida. We provide care for people suffering from diseases that may be alleviated by access to adult stem cell based regenerative treatment. We utilize a fat transfer surgical technology to isolate and implant the patient’s own stem cells from a small quantity of fat harvested by a mini-liposuction on the same day. The investigational protocols utilized by the Miami Stem Cell Treatment Center have been reviewed and approved by an IRB (Institutional Review Board) which is registered with the U.S. Department of Research Protections; and the study is registered with Clinicaltrials.gov, a service of the U.S. National Institute of Health. For more information, please visit our website at http://www.MiamiStemCellsUSA.com.

Read the full story at http://www.prweb.com/releases/stemcells/therapy/prweb11335881.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Public Interest in Medicinal Mushroom Information Reaches a New Record
2. Prosthetic hands viewed as eerie by the public new study shows
3. Research Links Mold With Parkinson's Disease, My Cleaning Products Suggests Mold Removal Sprays to Help Public Avoid the Illness and Spores' Other Health Effects
4. Beverly Hills Public Relations: Special Rate for Social Media Management
5. Construction Accident Lawyers Block O'Toole & Murphy, LLP Comment on OSHA's New Plan to Require Large Companies to Publicly File Their Workplace Accident Reports
6. OU natural products discovery group asks for publics help with citizen science program
7. Better tests needed to improve patient care, public health
8. New report calls for sustained public endorsement and funding for human stem cell research
9. Pitt Public Health analysis challenges assumptions about bisexual men and HIV transmission
10. The California Department of Public Health Lists Heart Disease and Stroke, as Leading Causes of Death in the State
11. Comprehensive Vein Treatment Center is Launching a New Social Media Campaign to Educate the Public about Safely Eliminating Varicose Veins
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a ... does not. Yisrayl says with so many titles and names for the Creator, it’s ... with a little Scripture, backed with a lot of research, the truth is undeniable. ...
(Date:4/28/2017)... York, New York (PRWEB) , ... April 28, ... ... high-quality anti-aging skincare and advanced nutraceutical supplements, through its Nova Skin ... cream provides the hydrating benefits of a moisturizer with the power of an ...
(Date:4/28/2017)... MEMPHIS, Tenn. (PRWEB) , ... April 28, 2017 , ... ... VeinViewer® system, today announced an alliance with B. Braun Medical Inc. , a ... central role in patient care with as many as 90 percent of hospital patients ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, ... the heels of Thinksport’s award-winning sunscreen they’ve used the same scientific approach to ... , Countless deodorants flood the aisles that contain harmful chemicals that should be ...
(Date:4/27/2017)... ... April 27, 2017 , ... Goodcents Deli Fresh Subs announced ... Lincoln, Neb. area this year. , The first new location will open at ... will open at 84th and Northern Lights Drive this fall. And the third location ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... LUND, Sweden , April 20, 2017 /PRNewswire/ ... OTCQX: NEVPF) ("NeuroVive") today announced positive preclinical ... company,s preclinical compound for non-alcoholic steatohepatitis (NASH), ... NV556 has previously ... STAM™ NASH model. Today, NeuroVive,s scientists present ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
Breaking Medicine Technology: